Showing results (171-180 of 209) with videos related to
Sort By:
Pageof 21
Inflammatory Bowel Diseases|June 18, 2015
miRNA-26b Overexpression in Ulcerative Colitis-associated CarcinogenesisNatalya Benderska, Anna-Lena Dittrich, Sabine Knaup, et al.Breast Cancer Research : BCR|February 28, 2018
Prognostic impact of CD4-positive T cell subsets in early breast cancer: a study based on the FinHer trial patient populationMarcus Schmidt, Veronika Weyer-Elberich, Jan G Hengstler, et al.European Urology|April 8, 2023
Molecular Urothelial Tumor Cell Subtypes Remain Stable During Metastatic EvolutionAlexander Cox, Niklas Klümper, Johannes Stein, et al.Oncotarget|March 31, 2018
A multicenter round robin test of PD-L1 expression assessment in urothelial bladder cancer by immunohistochemistry and RT-qPCR with emphasis on prognosis prediction after radical cystectomyMarkus Eckstein, Ralph M Wirtz, Carolin Pfannstil, et al.AJNR. American Journal of Neuroradiology|September 16, 2017
Predictors of Incomplete Occlusion following Pipeline Embolization of Intracranial Aneurysms: Is It Less Effective in Older Patients?N Adeeb, J M Moore, M Wirtz, et al.Wiener Klinische Wochenschrift|July 15, 2026
[Statement of the Austrian Society of Pneumology expert group for interstitial lung diseases and orphan diseases on the 2025 update of the international multidisciplinary classification of interstitial pneumonias]David Lang, Mathis Hochrainer, Kaveh Akbari, et al.International Journal of Molecular Sciences|July 27, 2022
Prediction of Response to Cisplatin-Based Neoadjuvant Chemotherapy of Muscle-Invasive Bladder Cancer Patients by Molecular Subtyping including KRT and FGFR Target Gene AssessmentThorsten H Ecke, Paula Carolin Voß, Thorsten Schlomm, et al.Journal of Translational Medicine|May 30, 2015
Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation studyAngelos Koutras, Konstantine T Kalogeras, Ralph M Wirtz, et al.British Journal of Cancer|November 6, 2008
Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) studyA K Koutras, K T Kalogeras, M-A Dimopoulos, et al.Translational Oncology|July 1, 2017
Evaluation of the Prognostic Value of RANK, OPG, and RANKL mRNA Expression in Early Breast Cancer Patients Treated with Anthracycline-Based Adjuvant ChemotherapyEleni Timotheadou, Konstantine T Kalogeras, Georgia-Angeliki Koliou, et al.Pageof 21